Introduction: Why Pharmaceuticals in 2026 Is a Growth Point
June 2026. The Russian pharmaceutical market is undergoing tectonic shifts. Since January 1, 2026, new amendments to Federal Law No. 61-FZ "On the Circulation of Medicinal Products" have come into force, tightening requirements for drug registration, pharmacy licensing, and pharmacovigilance. Simultaneously, artificial intelligence is being integrated into drug development and quality control processes—according to market analytics, over 40% of pharmaceutical manufacturers in Russia already use AI solutions to predict substance stability (source: open reports of the Pharmprom association for Q1 2026).
For professionals working in the field of medicinal product circulation, this means one thing: a deep understanding of the law and modern technologies is essential. The course "Medicinal Products and Pharmaceuticals" on the asibiont.com platform is designed for those who want not just to "refresh their knowledge" but to gain a systematic understanding of the entire chain—from registration to retail sales. In this article, we will explore why this course is relevant right now, what skills it provides, and how AI-based learning helps absorb complex material faster.
What Is the Course "Medicinal Products and Pharmaceuticals" and Who Is It For?
The course is a complete immersion into the legal and practical aspects of medicinal product circulation based on Federal Law No. 61-FZ. It is intended for:
- Pharmacy specialists (pharmacists, pharmaceutical chemists, managers) who want to understand new licensing and reporting requirements (since 2026, for example, pharmacies are required to maintain an electronic prescription log in a form approved by the Ministry of Health).
- Employees of pharmaceutical companies involved in drug registration—for whom it is critical to know the procedure for submitting documents to the Russian Ministry of Health and the nuances of expert review.
- Lawyers and managers working in the pharmaceutical sector—to competently handle transactions, review contracts, and avoid fines (which, according to Roszdravnadzor, increased by 18% in 2025 compared to 2024).
- Beginners who want to enter the profession with an "A to Z" understanding.
The course does not require specialized education—the material is provided with explanations of terms. However, a basic familiarity with pharmaceuticals will be an advantage.
What You Will Learn: Specific Skills and Knowledge
The course program is built around Federal Law No. 61-FZ and covers all stages of drug circulation. Here are the key blocks:
- State Registration of Medicinal Products—you will learn what documents are needed for registration (from the application to clinical trial results), how the expert review proceeds, and what changes came into effect in 2026 (e.g., new requirements for veterinary drug dossiers).
- Licensing of Pharmaceutical Activities—you will analyze requirements for premises, equipment, and pharmacy personnel, as well as the procedure for obtaining and renewing a license. The course includes sample documents: licenses, declarations, accounting logs.
- Rules for Wholesale and Retail Trade—you will study requirements for storage, transportation, and dispensing of drugs, including remote sales (relevant after the legalization of online sales of prescription drugs in 2024).
- Pharmacovigilance—how to track adverse effects, submit reports to Roszdravnadzor, and maintain records.
- Liability for Violations—administrative and criminal risks, fine amounts (e.g., for trafficking counterfeit drugs—up to 1 million rubles under Article 238.1 of the Criminal Code of the Russian Federation).
Practical value: after the course, you will be able to independently prepare a document package for drug registration, verify a pharmacy license for compliance with new standards, and avoid common reporting errors.
How Learning Works on asibiont.com: AI Personalization
The asibiont.com platform uses an approach that sets it apart from traditional online schools. At its core is AI generation of personalized lessons. How does it work?
- AI tutor (neural network) creates a program tailored to you. You specify your goals (e.g., "I want to understand drug registration for work in a pharmaceutical company"), and the neural network forms a sequence of lessons, adapting complexity and depth. If you are a beginner, the AI will explain basic concepts (e.g., what "circulation of medicinal products" means). If you are an experienced specialist, it will immediately move to the nuances of Federal Law No. 61-FZ and the 2026 changes.
- Text format with interactive elements. The platform has no video lessons—only structured texts that you can read at your own pace. The AI generates examples, diagrams, and self-test questions directly within the lesson. For example, after the section on licensing, you will be prompted to fill out a license application template—this helps reinforce the skill.
- 24/7 access. You are not tied to a schedule. You can study at any time—whether at night or on weekends.
Why is this effective? Research (e.g., a 2023 study by Carnegie Mellon University) shows that adaptive learning improves material retention by 30-50% compared to traditional lectures. The AI adjusts to your pace: if you quickly understand a topic, it moves on; if you encounter difficulties, it provides additional explanations and examples. The neural network does not respond in a chat (it is not a 24/7 AI tutor), but it generates content that answers your questions within the topic.
By the way, AI in pharmaceuticals is not just hype. Neural networks are already used to predict the stability of dosage forms (reducing experimental costs by 25-40%), and the course includes a module on the application of AI in pharmacovigilance—to keep you on trend.
Why AI Learning Is Exactly What Pharmaceuticals Needs?
Pharmaceutical legislation changes rapidly. New Ministry of Health orders, amendments to Federal Law No. 61-FZ, EAEU requirements—it is difficult to keep track of everything. Traditional courses often become outdated by the time they are recorded. The AI platform asibiont.com updates lessons based on the latest data: if a new registration regulation is released in mid-2026, the AI will adjust the program within a few days. This means you are always learning from current material.
Additionally, AI can explain complex legal formulations in simple language. For example, instead of a convoluted article from the law, you get an example: "Imagine you are a pharmacy. To sell prescription drugs, you need a license, and it must specify a specific address. If you open a new location, you will have to obtain a separate license." Such examples help you quickly grasp the concept.
Who the Course Is For: Target Audience Breakdown
| Category | Purpose of the Course | Specific Benefit |
|---|---|---|
| Pharmacists and pharmaceutical chemists | Update knowledge of Federal Law No. 61-FZ (especially after the 2026 amendments) | Avoid fines for improper storage or dispensing |
| Registration specialists | Systematize the document submission process | Reduce registration timelines for new drugs |
| Pharmacy owners or managers | Understand new licensing requirements | Quickly prepare documents for Roszdravnadzor inspections |
| Lawyers in pharmaceuticals | Understand industry specifics | Competently draft contracts and protect clients |
| Beginners | Enter the profession from scratch | Gain systematic knowledge without overpaying for "basic" courses |
The course materials include sample documents (licenses, declarations, prescriptions, logs)—a practical tool that can be used immediately after training.
Conclusion: Time to Act
Pharmaceuticals in 2026 is not only about strict laws but also opportunities. Those who understand Federal Law No. 61-FZ, licensing, and AI tools will be in demand in the job market. The course "Medicinal Products and Pharmaceuticals" on asibiont.com provides exactly this kind of knowledge—systematic, up-to-date, with practical samples.
Do not postpone learning. Start right now on asibiont.com—choose the course, specify your goals, and the AI neural network will generate a personalized program. Learn at your own pace, without videos or schedule constraints. Gain skills that will protect you from mistakes and open new career horizons.
Course link: [asibiont.com/lekarstvennye-sredstva-i-farmacevtika]
The article was written in June 2026 based on an analysis of Federal Law No. 61-FZ, data from Roszdravnadzor, and industry reports.
Comments